Michael Bell

Director of Finance/CFO at GUARDANT HEALTH, INC.

Net worth: 6 M $ as of 2026-05-30

57 year

50 connections

Health Technology

Commercial Services

Consumer Services

Profile

Presently, Michael Bell holds the position of Chief Financial Officer of Guardant Health, Inc. Mr. Bell previously occupied the position of Chief Financial & Chief Accounting Officer at CareDx, Inc., Chief Financial Officer for Singulex, Inc., Chief Financial Officer at Metabiota, Inc., Finance Director at Chiron Corp., Head-Finance for Novartis Corp., Chief Financial Officer at Novartis Vaccines & Diagnostics, Inc., Chief Financial Officer of Novartis Pharma AG, Principal at Deloitte & Touche LLP and Principal at Ernst & Young LLP (Missouri). He received an undergraduate degree from the University of Leicester.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
GUARDANT HEALTH, INC. 0.04%	2026-06-14	48,452 ( 0.04% )	6 M $	2026-05-30

Michael Bell active positions

Companies	Position	Start
GUARDANT HEALTH, INC.	Director of Finance/CFO	2021-01-04

All active positions of Michael Bell

Former positions of Michael Bell

Companies	Position	End
CAREDX, INC.	Director of Finance/CFO	2020-12-30
Metabiota, Inc. Metabiota, Inc. Miscellaneous Commercial ServicesCommercial Services provides science and data analytics.	Director of Finance/CFO	2017-02-28
Singulex, Inc. Singulex, Inc. Medical SpecialtiesHealth Technology Operates as an immunodiagnostics company	Director of Finance/CFO	2015-12-31
Novartis Corp. Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products	Director of Finance/CFO	2011-12-31
Novartis Vaccines & Diagnostics, Inc. Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products	Director of Finance/CFO	2011-12-31

See the detail of Michael Bell's experience

Training of Michael Bell

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Bell's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Chiron Corp. Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening	Health Technology
CareDx, Inc. CareDx, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic test kits and provides related testing services	Health Technology
Novartis Corp. Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products	Health Technology
Singulex, Inc. Singulex, Inc. Medical SpecialtiesHealth Technology Operates as an immunodiagnostics company	Health Technology
Metabiota, Inc. Metabiota, Inc. Miscellaneous Commercial ServicesCommercial Services provides science and data analytics.	Commercial Services
Guardant Health, Inc. Guardant Health, Inc. Medical SpecialtiesHealth Technology Develops blood and tissue test devices to detect cancer & provides related screening services	Health Technology
Deloitte & Touche LLP Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services	Commercial Services
Ernst & Young LLP (Missouri) Ernst & Young LLP (Missouri) Miscellaneous Commercial ServicesCommercial Services Provides accounting, audit, tax and business consulting services	Commercial Services
University of Leicester University of Leicester Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Novartis Vaccines & Diagnostics, Inc. Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products	Health Technology
Novartis Pharma AG Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company	Health Technology